Micro-RNA profiling in human serum reveals compartment-specific roles of miR-571 and miR-652 in liver cirrhosis

PLoS ONE

Volumn 7, Issue 3, 2012, Pages

  Roderburg, Christoph ^a   Mollnow, Tobias ^a   Bongaerts, Brenda ^b   Elfimova, Natalia ^c   Cardenas, David Vargas ^a   Berger, Katharina ^a   Zimmermann, Henning ^a   Koch, Alexander ^a   Vucur, Mihael ^a   Luedde, Mark ^d   Hellerbrand, Claus ^e   Odenthal, Margarete ^c   Trautwein, Christian ^a   Tacke, Frank ^a   Luedde, Tom ^a  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^b MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^c UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

^d UNIVERSITY OF KIEL   (Germany)

^e UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; BIOLOGICAL MARKER; CYTOKINE; MICRORNA; MIR 513 3P; MIR 571; MIR 652; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; MIRN571 MICRORNA, HUMAN; MIRN652 MICRORNA, HUMAN;

ADULT; AGED; ALCOHOL LIVER CIRRHOSIS; ARTICLE; CELL ISOLATION; CHRONIC LIVER DISEASE; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; GENETIC SCREENING; HEPATITIS C; HUMAN; HUMAN CELL; HUMAN TISSUE; INTRACELLULAR SPACE; LIVER CELL; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; MICROARRAY ANALYSIS; MONOCYTE; POLYMERASE CHAIN REACTION; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; RNA ANALYSIS; STELLATE CELL; UPREGULATION; BLOOD; CLUSTER ANALYSIS; DISEASE COURSE; FIBROSIS; GENE EXPRESSION PROFILING; GENETICS; HEMATOPOIETIC STEM CELL; INFLAMMATION; METABOLISM; MIDDLE AGED; SIGNAL TRANSDUCTION;

BACTERIA (MICROORGANISMS); HEPATITIS C VIRUS; RODENTIA;

ADULT; AGED; AGED, 80 AND OVER; CLUSTER ANALYSIS; DISEASE PROGRESSION; FEMALE; FIBROSIS; GENE EXPRESSION PROFILING; HEMATOPOIETIC STEM CELLS; HUMANS; INFLAMMATION; INTRACELLULAR SPACE; LIVER CIRRHOSIS; MALE; MICRORNAS; MIDDLE AGED; MONOCYTES; SIGNAL TRANSDUCTION; YOUNG ADULT;

EID: 84857866299     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0032999     Document Type: Article

References (40)

1. Schuppan D, Afdhal NH, (2008) Liver cirrhosis. Lancet 371: 838-851.
2. Gieling RG, Burt AD, Mann DA, (2008) Fibrosis and cirrhosis reversibility- molecular mechanisms. Clin Liver Dis 12: 915-937, xi.
3. Kloosterman WP, Plasterk RH, (2006) The diverse functions of microRNAs in animal development and disease. Dev Cell 11: 441-450.
4. Huang Y, Shen XJ, Zou Q, Wang SP, Tang SM, et al. (2011) Biological functions of microRNAs: a review. J Physiol Biochem 67: 129-139.
5. Ha TY, (2011) MicroRNAs in Human Diseases: From Cancer to Cardiovascular Disease. Immune Netw 11: 135-154.
6. Wang K, Zhang S, Marzolf B, Troisch P, Brightman A, et al. (2009) Circulating microRNAs, potential biomarkers for drug-induced liver injury. Proc Natl Acad Sci U S A 106: 4402-4407.
7. Li YP, Gottwein JM, Scheel TK, Jensen TB, Bukh J, (2011) MicroRNA-122 antagonism against hepatitis C virus genotypes 1-6 and reduced efficacy by host RNA insertion or mutations in the HCV 5′ UTR. Proc Natl Acad Sci U S A 108: 4991-4996.
8. Ding J, Huang S, Wu S, Zhao Y, Liang L, et al. (2010) Gain of miR-151 on chromosome 8q24.3 facilitates tumour cell migration and spreading through downregulating RhoGDIA. Nat Cell Biol 12: 390-399.
9. Hou J, Lin L, Zhou W, Wang Z, Ding G, et al. (2011) Identification of miRNomes in human liver and hepatocellular carcinoma reveals miR-199a/b-3p as therapeutic target for hepatocellular carcinoma. Cancer Cell 19: 232-243.
10. Roderburg C, Urban GW, Bettermann K, Vucur M, Zimmermann H, et al. (2011) Micro-RNA profiling reveals a role for miR-29 in human and murine liver fibrosis. Hepatology 53: 209-218.
11. Bandyopadhyay S, Friedman RC, Marquez RT, Keck K, Kong B, et al. (2011) Hepatitis C virus infection and hepatic stellate cell activation downregulate miR-29: miR-29 overexpression reduces hepatitis C viral abundance in culture. J Infect Dis 203: 1753-1762.
12. Sekiya Y, Ogawa T, Yoshizato K, Ikeda K, Kawada N, (2011) Suppression of hepatic stellate cell activation by microRNA-29b. Biochem Biophys Res Commun 412: 74-79.
13. Thum T, Gross C, Fiedler J, Fischer T, Kissler S, et al. (2008) MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts. Nature 456: 980-984.
14. Varnholt H, Drebber U, Schulze F, Wedemeyer I, Schirmacher P, et al. (2008) MicroRNA gene expression profile of hepatitis C virus-associated hepatocellular carcinoma. Hepatology 47: 1223-1232.
15. Zimmermann HW, Seidler S, Nattermann J, Gassler N, Hellerbrand C, et al. (2010) Functional contribution of elevated circulating and hepatic non-classical CD14CD16 monocytes to inflammation and human liver fibrosis. PLoS One 5: e11049.
16. Mendrick DL, (2011) Transcriptional profiling to identify biomarkers of disease and drug response. Pharmacogenomics 12: 235-249.
17. Cermelli S, Ruggieri A, Marrero JA, Ioannou GN, Beretta L, (2011) Circulating microRNAs in patients with chronic hepatitis C and non-alcoholic fatty liver disease. PLoS One 6: e23937.
18. Cortez MA, Bueso-Ramos C, Ferdin J, Lopez-Berestein G, Sood AK, et al. (2011) MicroRNAs in body fluids-the mix of hormones and biomarkers. Nat Rev Clin Oncol 8: 467-477.
19. Jungebluth P, Alici E, Baiguera S, Le Blanc K, Blomberg P, et al. (2011) Tracheobronchial transplantation with a stem-cell-seeded bioartificial nanocomposite: a proof-of-concept study. Lancet 378: 1997-2004.
20. Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, et al. (2008) Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci U S A 105: 10513-10518.
21. Wanninger J, Neumeier M, Bauer S, Weiss TS, Eisinger K, et al. (2011) Adiponectin induces the transforming growth factor decoy receptor BAMBI in human hepatocytes. FEBS Lett 585: 1338-1344.
22. Estep M, Armistead D, Hossain N, Elarainy H, Goodman Z, et al. (2010) Differential expression of miRNAs in the visceral adipose tissue of patients with non-alcoholic fatty liver disease. Aliment Pharmacol Ther 32: 487-497.
23. Duisters RF, Tijsen AJ, Schroen B, Leenders JJ, Lentink V, et al. (2009) miR-133 and miR-30 regulate connective tissue growth factor: implications for a role of microRNAs in myocardial matrix remodeling. Circ Res 104: 170-178, 176p following 178.
24. Estep M, Armistead D, Hossain N, Elarainy H, Goodman Z, et al. (2010) Differential expression of miRNAs in the visceral adipose tissue of patients with non-alcoholic fatty liver disease. Aliment Pharmacol Ther 32: 487-497.
25. Xie T, Liang J, Guo R, Liu N, Noble PW, et al. (2011) Comprehensive microRNA analysis in bleomycin-induced pulmonary fibrosis identifies multiple sites of molecular regulation. Physiol Genomics 43: 479-487.
26. Pineau P, Volinia S, McJunkin K, Marchio A, Battiston C, et al. (2010) miR-221 overexpression contributes to liver tumorigenesis. Proc Natl Acad Sci U S A 107: 264-269.
27. Bihrer V, Friedrich-Rust M, Kronenberger B, Forestier N, Haupenthal J, et al. (2011) Serum miR-122 as a biomarker of necroinflammation in patients with chronic hepatitis C virus infection. Am J Gastroenterol 106: 1663-1669.
28. Bihrer V, Waidmann O, Friedrich-Rust M, Forestier N, Susser S, et al. (2011) Serum microRNA-21 as marker for necroinflammation in hepatitis C patients with and without hepatocellular carcinoma. PLoS One 6: e26971.
29. Valadi H, Ekstrom K, Bossios A, Sjostrand M, Lee JJ, et al. (2007) Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol 9: 654-659.
30. Vickers KC, Palmisano BT, Shoucri BM, Shamburek RD, Remaley AT, (2011) MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins. Nat Cell Biol 13: 423-433.
31. Zimmermann HW, Seidler S, Gassler N, Nattermann J, Luedde T, et al. (2011) Interleukin-8 is activated in patients with chronic liver diseases and associated with hepatic macrophage accumulation in human liver fibrosis. PLoS One 6: e21381.
32. Bataller R, Brenner DA, (2005) Liver fibrosis. J Clin Invest 115: 209-218.
33. Luedde T, Schwabe RF, (2011) NF-kappaB in the liver-linking injury, fibrosis and hepatocellular carcinoma. Nat Rev Gastroenterol Hepatol 8: 108-118.
34. Gressner OA, Lahme B, Rehbein K, Siluschek M, Weiskirchen R, et al. (2008) Pharmacological application of caffeine inhibits TGF-beta-stimulated connective tissue growth factor expression in hepatocytes via PPARgamma and SMAD2/3-dependent pathways. J Hepatol 49: 758-767.
35. Wu XL, Zeng WZ, Jiang MD, Qin JP, Xu H, (2008) Effect of Oxymatrine on the TGFbeta-Smad signaling pathway in rats with CCl4-induced hepatic fibrosis. World J Gastroenterol 14: 2100-2105.
36. Chen X, Ba Y, Ma L, Cai X, Yin Y, et al. (2008) Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res 18: 997-1006.
37. Peltier HJ, Latham GJ, (2008) Normalization of microRNA expression levels in quantitative RT-PCR assays: identification of suitable reference RNA targets in normal and cancerous human solid tissues. RNA 14: 844-852.
38. Hummel R, Hussey DJ, Haier J, (2010) MicroRNAs: predictors and modifiers of chemo- and radiotherapy in different tumour types. Eur J Cancer 46: 298-311.
39. Resnick KE, Alder H, Hagan JP, Richardson DL, Croce CM, et al. (2009) The detection of differentially expressed microRNAs from the serum of ovarian cancer patients using a novel real-time PCR platform. Gynecol Oncol 112: 55-59.
40. Fuller-Pace FV, (2006) DExD/H box RNA helicases: multifunctional proteins with important roles in transcriptional regulation. Nucleic Acids Res 34: 4206-4215.